United States Diabetes Care Devices Market Outlook to 2022-Glucose Monitoring and Insulin Delivery

United States Diabetes Care Devices Market Outlook to 2022-Glucose Monitoring and Insulin Delivery


  • Products Id :- GDMEMC0196DB
  • |
  • Pages: 488
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

United States Diabetes Care Devices Market Outlook to 2022-Glucose Monitoring and Insulin Delivery

Summary

GlobalData's new report, "United States Diabetes Care Devices Market Outlook to 2022", provides key market data on the United States Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size for Diabetes Care Devices market categories-Glucose Monitoring and Insulin Delivery.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.

2015 company shares and distribution shares data for Diabetes Care Devices market.

Global corporate-level profiles of key companies operating within the United States Diabetes Care Devices market.

Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.

Reasons to Buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Diabetes Care Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Diabetes Care Devices Market, United States 11

3.1 Diabetes Care Devices Market, United States, Revenue ($m), 2008-2022 11

3.2 Diabetes Care Devices Market, United States, Revenue Mix ($m), 2015 12

3.3 Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2015 13

3.4 Diabetes Care Devices Market, United States, Revenue ($m), 2008-2015 14

3.5 Diabetes Care Devices Market, United States, Revenue ($m), 2015-2022 16

3.6 Diabetes Care Devices Market, United States, Volume (Units), 2008-2022 18

3.7 Diabetes Care Devices Market, United States, Volume (Units), 2008-2015 19

3.8 Diabetes Care Devices Market, United States, Volume (Units), 2015-2022 21

3.9 Diabetes Care Devices Market, United States, Company Share by Revenue ($m), 2015 23

4 Glucose Monitoring Market, United States 25

4.1 Glucose Monitoring Market, United States, Revenue Mix ($m), 2015 25

4.2 Glucose Monitoring Market, United States, Segment Contribution (%), 2015 26

4.3 Glucose Monitoring Market, United States, Revenue ($m), 2008-2015 27

4.4 Glucose Monitoring Market, United States, Revenue ($m), 2015-2022 29

4.5 Glucose Monitoring Market, United States, Volume (Units), 2008-2015 35

4.6 Glucose Monitoring Market, United States, Volume (Units), 2015-2022 37

4.7 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2014-2015 43

4.8 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2015 44

5 Insulin Delivery Market, United States 46

5.1 Insulin Delivery Market, United States, Revenue Mix ($m), 2015 46

5.2 Insulin Delivery Market, United States, Segment Contribution (%), 2015 47

5.3 Insulin Delivery Market, United States, Revenue ($m), 2008-2015 48

5.4 Insulin Delivery Market, United States, Revenue ($m), 2015-2022 50

5.5 Insulin Delivery Market, United States, Volume (Units), 2008-2015 60

5.6 Insulin Delivery Market, United States, Volume (Units), 2015-2022 62

5.7 Insulin Delivery Market, United States, Distribution Share by Revenue ($m), 2014-2015 72

5.8 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2015 73

6 Overview of Key Companies in United States, Diabetes Care Devices Market 75

6.1 Medtronic plc 75

6.2 Eli Lilly and Company 75

6.3 LifeScan Inc 75

6.4 Becton Dickinson and Co 76

6.5 Bayer HealthCare AG 76

6.6 Novo Nordisk A/S 76

6.7 Abbott Laboratories 77

6.8 Insulet Corp 77

6.9 DexCom Inc 77

6.10 F. Hoffmann-La Roche Ltd 77

6.11 Sanofi 78

6.12 Trividia Health Inc 78

7 Diabetes Care Devices Market Pipeline Products 79

8 Financial Deals Landscape 80

8.1 Acquisition 80

8.2 Debt Offerings 88

8.3 Equity Offerings 133

8.4 Partnerships 140

8.5 Private Equity 156

8.6 Venture Financing 157

9 Recent Developments 171

9.1 Corporate Communications 171

9.2 Financial Announcements 221

9.3 Government and Public Interest 398

9.4 Legal And Regulatory 401

9.5 Other Significant Developments 415

9.6 Product News 447

9.7 Strategy And Business Planning 459

10 Appendix 473

10.1 Research Methodology 474

10.2 GlobalData Consulting 476

10.3 Contact Us 476

10.4 Disclaimer 477

1.2 List of Figures

Figure 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2008-2022 22

Figure 2: Diabetes Care Devices Market, United States, Revenue Mix ($m), 2015 23

Figure 3: Diabetes Care Devices Market, United States, Category Contribution (%), 2015 24

Figure 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 25

Figure 5: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 27

Figure 6: Diabetes Care Devices Market, United States, Volume (Units), 2008-2022 29

Figure 7: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2008-2015 30

Figure 8: Diabetes Care Devices Market, United States, Volume (Units), Forecast, 2015-2022 32

Figure 9: Diabetes Care Devices Market, United States, Company Share (%) 2015 34

Figure 10: Glucose Monitoring Market, United States, Revenue Mix ($m), 2015 36

Figure 11: Glucose Monitoring Market, United States, Segment Contribution (%), 2015 37

Figure 12: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 38

Figure 13: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 40

Figure 14: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 42

Figure 15: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 44

Figure 16: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015 46

Figure 17: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022 48

Figure 18: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015 50

Figure 19: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022 52

Figure 20: Glucose Monitoring Market, United States, Company Share (%) 2015 55

Figure 21: Insulin Delivery Market, United States, Revenue Mix ($m), 2015 57

Figure 22: Insulin Delivery Market, United States, Segment Contribution (%), 2015 58

Figure 23: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 59

Figure 24: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 61

Figure 25: Insulin Pens Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 63

Figure 26: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 65

Figure 27: Insulin Pens Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 67

Figure 28: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 69

Figure 29: Insulin Delivery Market, United States, Volume (Units), Historic, 2008-2015 71

Figure 30: Insulin Delivery Market, United States, Volume (Units), Forecast, 2015-2022 73

Figure 31: Insulin Pens Market, United States, Volume (Units), Historic, 2008-2015 75

Figure 32: Insulin Pumps Market, United States, Volume (Units), Historic, 2008-2015 77

Figure 33: Insulin Pens Market, United States, Volume (Units), Forecast, 2015-2022 79

Figure 34: Insulin Pumps Market, United States, Volume (Units), Forecast, 2015-2022 81

Figure 35: Insulin Delivery Market, United States, Company Share (%) 2015 84

1.1 List of Tables

Table 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2008-2022 22

Table 2: Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2015 24

Table 3: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 26

Table 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 28

Table 5: Diabetes Care Devices Market, United States, Volume (Units), 2008-2022 29

Table 6: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2008-2015 31

Table 7: Diabetes Care Devices Market, United States, Volume (Units), Forecast, 2015-2022 33

Table 8: Diabetes Care Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2015 35

Table 9: Glucose Monitoring Market, United States, Segment Contribution (%), 2015 37

Table 10: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 39

Table 11: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 41

Table 12: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 43

Table 13: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 45

Table 14: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015 47

Table 15: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022 49

Table 16: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015 51

Table 17: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022 53

Table 18: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 54

Table 19: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2015 56

Table 20: Insulin Delivery Market, United States, Segment Contribution (%), 2015 58

Table 21: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 60

Table 22: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 62

Table 23: Insulin Pens Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 64

Table 24: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 66

Table 25: Insulin Pens Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 68

Table 26: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 70

Table 27: Insulin Delivery Market, United States, Volume (Units), Historic, 2008-2015 72

Table 28: Insulin Delivery Market, United States, Volume (Units), Forecast, 2015-2022 74

Table 29: Insulin Pens Market, United States, Volume (Units), Historic, 2008-2015 76

Table 30: Insulin Pumps Market, United States, Volume (Units), Historic, 2008-2015 78

Table 31: Insulin Pens Market, United States, Volume (Units), Forecast, 2015-2022 80

Table 32: Insulin Pumps Market, United States, Volume (Units), Forecast, 2015-2022 82

Table 33: Insulin Delivery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 83

Table 34: Insulin Delivery Market, United States, Company Share by Revenue ($m), USD Constant, 2015 85

Table 35: Diabetes Care Devices Market Pipeline Products 90

Table 36: BioTelemetry Acquires Telcare Medical Supply and Associated Assets 91

Table 37: CRF Health Acquires Entra Health Systems 92

Table 38: Abbott Labs to Acquire Alere 93

Table 39: Liberty Medical Acquires Neighborhood Diabetes from Insulet for USD5 Million 95

Table 40: MannKind May Sell Itself 97

Table 41: Teleflex Acquires Nostix 98

Table 42: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 99

Table 43: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 101

Table 44: Abbott Labs Prices Public Offering of 2.35% Notes due 2019 for USD2.9 Billion 103

Table 45: Abbott Labs Prices Public Offering of 2.9% Notes due 2021 for USD2.85 Billion 105

Table 46: Abbott Labs Prices Public Offering of 3.4% Notes due 2023 for USD1.5 Billion 107

Table 47: Abbott Labs Prices Public Offering of 3.75% Notes due 2026 for USD3 Billion 109

Table 48: Abbott Labs Prices Public Offering of 4.75% Notes due 2036 for USD1.7 Billion 111

Table 49: Abbott Labs Prices Public Offering of 4.9% Notes due 2046 for USD3.3 Billion 113

Table 50: Pfizer Raises USD1 Billion in Public Offering of 1.7% Notes Due 2019 115

Table 51: Pfizer Raises USD1 Billion in Public Offering of 2.2% Notes Due 2021 117

Table 52: Pfizer Raises USD1.8 Billion in Public Offering of 3% Notes Due 2026 119

Table 53: Pfizer Raises USD1 Billion in Public Offering of 4% Notes Due 2036 121

Table 54: Pfizer Raises USD1.3 Billion in Public Offering of 4.125% Notes Due 2046 123

Table 55: Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 125

Table 56: Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028 127

Table 57: Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 129

Table 58: Insulet Raises Private Placement of Senior Notes for USD300 Million 131

Table 59: Pfizer Raises USD1.25 Billion in Public Offering of 1.2% Notes Due 2018 132

Table 60: Pfizer Raises USD0.85 Billion in Public Offering of 1.45% Notes Due 2019 134

Table 61: Pfizer Raises USD1.15 Billion in Public Offering of 1.95% Notes Due 2021 136

Table 62: Pfizer Raises USD1.25 Billion in Public Offering of 2.75% Notes Due 2026 138

Table 63: Pfizer Raises USD0.5 Billion in Public Offering of 4.4% Notes Due 2044 140

Table 64: Echo Therapeutics Raises USD3.4 Million in Second and Final Tranche of Private Placement of Notes and Warrants 142

Table 65: Echo Therapeutics Raises USD1.8 Million in First Tranche Private Placement of Notes and Warrants 143

Table 66: GI Dynamics to Raise USD1.2 Million in Private Placement of CDIs 144

Table 67: ConvaTec Raises USD1.8 Billion in IPO 145

Table 68: Mannkind Prices Shares Issue for USD50 Million 146

Table 69: Valeritas Raises USD25 Million in Private Placement of Shares 147

Table 70: Senseonics Raises USD45 Million in Public Offering of Shares 148

Table 71: PharmaCyte Biotech Raises USD1 Million in Private Placement of shares 150

Table 72: Defymed Enters into Agreement with Semma Therapeutics 151

Table 73: Becton, Dickinson Enters into Research Agreement with Juvenile Diabetes Research Foundation 152

Table 74: Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies 153

Table 75: WellDoc Enters into Agreement with LifeScan 154

Table 76: Sanofi and Verily Life Sciences Form Joint Venture 155

Table 77: JDRF Enters into Co-Development Agreement with Arecor 156

Table 78: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 157

Table 79: Profil Institute for Clinical Research Enters into Agreement with mySugr 158

Table 80: Diasend Partners with Abbott Labs 159

Table 81: Medtronic and Qualcomm Life Enter into Co-Development Agreement 160

Table 82: InSpark Technologies Enters into Agreement with Atlanta Diabetes Associates and East Carolina Diabetes and Obesity Institute 161

Table 83: Metabolon Enters into Licensing Agreement with Synlab 162

Table 84: LifeScan Enters into Agreement with WellDoc 163

Table 85: Insulet Enters into Licensing Agreement with Mode AGC 164

Table 86: Senseonics Enters into Agreement with Diasend 165

Table 87: Insulet Enters into Co-Development Agreement with Eli Lilly 166

Table 88: Warburg Pincus to Invest in Hygiena 167

Table 89: Intuity Medical Raises USD40 Million in Series 3 Financing 168

Table 90: Bigfoot Biomedical Raises USD35.5 Million in Series A Financing 170

Table 91: Glooko Raises USD8 Million in Financing Round 171

Table 92: Dance Biopharm Raises USD0.625 Million in Venture Financing 172

Table 93: Eccrine Systems Raises USD4.56 Million in Venture Financing 173

Table 94: Common Sensing Raises USD1.6 Million in Financing Round 174

Table 95: Optiscan Biomedical Raises USD29.5 Million in Financing Round 175

Table 96: DexCom Raises USD7.2 Million in Venture Financing 176

Table 97: Livongo Health Raises USD44.5 Million in Series C Financing Round 177

Table 98: WellDoc Raises USD7.5 Million in Extended Series B Financing 179

Table 99: Epinex Diagnostics Raises USD0.1 Million in Venture Financing 180

Table 100: Bigfoot Biomedical Raises USD2.37 Million in Venture Financing 181

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Medtronic plc, Eli Lilly and Company, LifeScan Inc, Becton Dickinson and Co, Bayer HealthCare AG, Novo Nordisk A/S, Abbott Laboratories, Insulet Corp, DexCom Inc, F. Hoffmann-La Roche Ltd, Sanofi, Trividia Health Inc

Diabetes Care Devices, Glucose Monitoring, Insulin Delivery, Blood Glucose Meters, Lancets, Blood Glucose Test Strips, Insulin Pens, Insulin Syringes, Insulin Pumps, Traditional Insulin Pump Accessories, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic plc, Novo Nordisk A/S, Bayer HealthCare AG, Sanofi, Eli Lilly and Company, Abbott Laboratories, Becton Dickinson and Co, Arkray Inc, Animas Corp, Insulet Corp, Nipro Corp

select a license

Single User License
USD 5995 INR 383800
Site License
USD 11990 INR 767600
Corporate User License
USD 17985 INR 1151400

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com